Defendant
1 case as defendant.
CLARET EUROPEAN SPECIALTY LENDING COMPANY III, S.A R.L. is a Luxembourg-based investment vehicle associated with Claret Capital Partners, a leading independent growth debt fund manager headquartered in London, United Kingdom. Claret Capital Partners was founded in 2013 and manages over $1 billion in assets. The entity, CLARET EUROPEAN SPECIALTY LENDING COMPANY III, S.A R.L., is involved in the acquisition and management of shareholdings and other financial instruments as part of its investment activities.
Claret Capital Partners specializes in providing tailored growth debt to innovative European small and medium-sized enterprises (SMEs) across the technology, life sciences, and climate tech sectors. Since its inception, Claret Capital has invested over €1.2 billion in more than 190 companies, offering less dilutive capital to support organic growth, acquisitions, and R&D.
In terms of patent litigation, CLARET EUROPEAN SPECIALTY LENDING COMPANY III, S.A R.L. maintains a defensive posture, having been named as a defendant in one tracked case. This single instance occurred in the Delaware District Court, where it was sued by Neurent Medical Ltd. The company does not appear as a plaintiff in any patent litigation, indicating it is an operating entity defending against a suit rather than a non-practicing entity.
This is an active litigation case filed in the Delaware District Court, with Neurent Medical Ltd as the plaintiff and CLARET EUROPEAN SPECIALTY LENDING COMPANY III, S.A R.L. as the defendant.